Gleevec is approved to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), and the letter spells out the approved uses and dosaging, along with a host of violations, which the FDA describes as so “serious” ...
Gleevec is approved to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), and the letter spells out the approved uses and dosaging, along with a host of violations, which the FDA describes as so “serious” ..._.jpg)
Gleevec is approved to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), and the letter spells out the approved uses and dosaging, along with a host of violations, which the FDA describes as so “serious” ...
Released an April 21 warning letter to Novartis AG over. two false, misleading websites for its Gleevec cancer drug. * In letter, said Novartis websites promote Gleevec for. an unapproved use, do not disclose risks, make unproven claims ...
Gleevec is approved to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), and the letter spells out the approved uses and dosaging, along with a host of violations, which the FDA describes as so “serious” ...
No comments:
Post a Comment